The senator says he is all about economic development for North Louisiana and wants to build on assets. He says the facility ...

Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.

Dr. Reddy's Laboratories (NYSE:RDY) has denied reports that the company will be laying off its workforce to cut labor costs by 25%, calling it "factually incorrect." The Business Standard report ...

Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.07% to 1,159.90 Indian rupees Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX Index ...

Dr. Reddy's Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based pharmaceutical giant dismissed claims of layoffs targeting high-earning ...

Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it ...